Leerink Capital Partners Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Leerink Capital Partners's estimated annual revenue is currently $35M per year.(i)
  • Leerink Capital Partners's estimated revenue per employee is $376,344

Employee Data

  • Leerink Capital Partners has 93 Employees.(i)
  • Leerink Capital Partners grew their employee count by 4% last year.

Leerink Capital Partners's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
Vice Chairman, Global Co-Head Investment Banking and Global Co-Head Healthcare Investment BankingReveal Email/Phone
3
Head Infrastructure EngineeringReveal Email/Phone
4
SVP, Institutional SalesReveal Email/Phone
5
VP, Account ManagerReveal Email/Phone
6
Director Applications DevelopmentReveal Email/Phone
7
Managing DirectorReveal Email/Phone
8
Director, BiotechnologyReveal Email/Phone
9
Senior Managing Director, Head Healthcare Equity Capital MarketsReveal Email/Phone
10
Managing DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A49-6%N/AN/A
#2
$15M320%N/AN/A
#3
$35M53-10%N/AN/A
#4
$35M934%N/AN/A
#5
$750M25-63%N/AN/A
#6
$3.5M58-19%N/AN/A
#7
$3.5M18-10%N/AN/A
#8
$35M355-9%N/AN/A
#9
$15M12734%N/AN/A
#10
N/A818%N/AN/A
Add Company

What Is Leerink Capital Partners?

Leerink Swann & Company is a full-service investment banking firm that provides institutional sales, healthcare equity research, corporate finance, and asset management services for high-net-worth clients. Leerink Swann & Company was voted Best Firm in both Biotechnology and Pharmaceuticals/Specialty Pharmaceuticals in the December 2001 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp is comprised of more than 3,000 consultants who are practicing physicians, surgeons, and biomedical professionals representing 55 clinical care specialties and 22 basic science disciplines.

keywords:N/A

N/A

Total Funding

93

Number of Employees

$35M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Leerink Capital Partners News

2022-04-20 - Investment Analysts' Weekly Ratings Updates for Anthem ...

They now have an “outperform” rating on the stock. 4/21/2022 – Anthem had its price target raised by analysts at SVB Leerink LLC from $483.00 to...

2022-04-20 - Illumina, Inc. (NASDAQ:ILMN) Given Consensus ...

SVB Leerink cut their price target on Illumina from $430.00 to ... Corient Capital Partners LLC increased its stake in Illumina by 1.7%...

2022-04-17 - FY2025 EPS Estimates for Marinus Pharmaceuticals, Inc ...

SVB Leerink analyst M. Goodman now expects that the biopharmaceutical ... GSA Capital Partners LLP purchased a new position in Marinus...

2019-01-09 - SVB Financial Group Acquires Leerink Holdings

SVB Financial Group (NASDAQ: SIVB), the parent company of Silicon Valley Bank, completed the acquisition of Leerink Holdings LLC, a Boston, MA-based parent company of healthcare and life science investment bank Leerink Partners. The amount of the deal was $280 million in cash up front to the un ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M93-2%N/A
#2
$15M93-7%N/A
#3
$14M93-10%N/A
#4
$16.7M93-1%N/A
#5
$13.5M93-10%$29.3M